{"head":{"version":"1.1.0","author":"听雨荷","course":"学习通","filename":"补体 单元测验","type_all_num":19,"time":"25年01月09日13小时49分27秒","id":"id-m5ows2w1-ctubvoj7d"},"body":[{"questions":"补体三条激活途径的共同点是（）","options":[" 所需离子相同"," 参与的补体成分相同"," C3转化酶的组成相同"," 具有共同的末端通路即MAC的形成及其溶解细胞效应相同"," 激活物质相同"],"type":"单选题","type_code":1,"answers":" D","answers_matching_index":[3],"analysis":[]},{"questions":"血清中含量最高的补体固有成分是（）","options":[" C1"," C9"," B因子"," C3"," C5"],"type":"单选题","type_code":1,"answers":" D","answers_matching_index":[3],"analysis":[]},{"questions":"经典途径中激活补体能力最强的Ig是（）","options":[" IgM"," IgG3\n\n"," IgG2\n\n"," IgG1\n\n"," IgA"],"type":"单选题","type_code":1,"answers":" A","answers_matching_index":[0],"analysis":[]},{"questions":"补体的膜攻击复合物（MAC）是（）","options":[" C5b~8"," C6b~9"," C5b~7"," C6b~8"," C5b~9"],"type":"单选题","type_code":1,"answers":" E","answers_matching_index":[4],"analysis":[]},{"questions":"补体促进吞噬细胞的吞噬作用被称为补体的（）","options":[" 炎症介质作用"," 调理作用"," 免疫粘附作用"," 溶菌和细胞毒作用"," 中和及溶解病毒作用"],"type":"单选题","type_code":1,"answers":" B","answers_matching_index":[1],"analysis":[]},{"questions":"能抑制C1r和C1s酶活性的补体调节因子是（）","options":[" C8bp"," DAF"," C1INH"," S蛋白"," C4bp"],"type":"单选题","type_code":1,"answers":" C","answers_matching_index":[2],"analysis":[]},{"questions":"补体经典激活途径的C5转化酶是（）","options":[" C3bnBb"," C3bBbP"," C4b2a"," C4b2a3b"," C5b~9"],"type":"单选题","type_code":1,"answers":" D","answers_matching_index":[3],"analysis":[]},{"questions":"具有较强的趋化作用和过敏毒素作用的补体裂解片段是（）","options":[" C3a"," C3b"," C4a"," C5a"," C2a"],"type":"单选题","type_code":1,"answers":" D","answers_matching_index":[3],"analysis":[]},{"questions":"在抗感染过程中，补体发挥作用依次出现的途径是（）","options":[" 经典途径-MBL途径-旁路途径"," 旁路途径-经典途径-MBL途径"," 旁路途径-MBL途径-经典途径"," 经典途径-旁路途径-MBL途径"," MBL途径-经典途径-旁路途径"],"type":"单选题","type_code":1,"answers":" C","answers_matching_index":[2],"analysis":[]},{"questions":"补体系统激活必须参加的成分是（）","options":[" C1s、C1r"," C4和C2"," B因子和D因子"," C3、C5~C9"," D因子和P因子"],"type":"单选题","type_code":1,"answers":" D","answers_matching_index":[3],"analysis":[]},{"questions":"补体经典激活途径中形成的C5转化酶是:","options":[" C4b2a"," C3bBb"," C4b2a3b"," C3bnBb"," C3bBbP"],"type":"单选题","type_code":1,"answers":" C","answers_matching_index":[2],"analysis":[]},{"questions":"下列哪项不是补体的生物学功能:","options":[" 溶细胞作用"," 调理作用"," 免疫粘附"," 炎症介质作用"," ADCC"],"type":"单选题","type_code":1,"answers":" E","answers_matching_index":[4],"analysis":[]},{"questions":"参与补体经典途径激活的Ig是:","options":[" IgM和IgE"," IgG和IgM"," IgA和IgG"," IgE和IgG"," IgE和IgD"],"type":"单选题","type_code":1,"answers":" B","answers_matching_index":[1],"analysis":[]},{"questions":"参与经典、旁路及MBL三条激活途径共同的补体成分是:","options":[" C1"," C2"," C3"," C4"," B因子"],"type":"单选题","type_code":1,"answers":" C","answers_matching_index":[2],"analysis":[]},{"questions":"能抑制C1r 和C1s 酶活性的补体调节因子是()","options":[" C8bp"," DAF (CD55)"," C1INH"," S蛋白"," C4bp"],"type":"单选题","type_code":1,"answers":" C","answers_matching_index":[2],"analysis":[]},{"questions":"在抗感染过程中,补体发挥作用依次出现的途径是","options":[" 经典途径-MBL途径-旁路途径"," 旁路途径-经典途径-MBL途径"," 旁路途径-MBL途径-经典途径"," 经典途径-旁路途径-MBL途径"," MBL途径-经典途径-旁路途径"],"type":"单选题","type_code":1,"answers":" C","answers_matching_index":[2],"analysis":[]},{"questions":"具有补体C1q结合位点的 Ig 是","options":[" IgM和IgD"," IgG和IgA的某些亚类"," IgM和IgA的某些亚类"," IgM和IgG的某些亚类"," IgA和IgD"],"type":"单选题","type_code":1,"answers":" D","answers_matching_index":[3],"analysis":[]},{"questions":"补体三条激活途径的共同点是()","options":[" 所需离子相同"," 参与的补体成分相同"," C3转化酶的组成相同"," 具有共同的末端通路即MAC的形成及其溶解细胞效应相同"," 激活物质相同"],"type":"单选题","type_code":1,"answers":" D","answers_matching_index":[3],"analysis":[]},{"questions":"补体的攻膜复合物(MAC)是","options":[" C5b~8"," C6b~9"," C5b~7"," C6b~8"," C5b~9"],"type":"单选题","type_code":1,"answers":" E","answers_matching_index":[4],"analysis":[]}]}